Next-Generation Biomanufacturing Market - Top Companies and Manufacturers

  • Report ID: 5958
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Companies Dominating the Next-Generation Biomanufacturing Landscape

    • Sartorius AG
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Regeneron Pharmaceuticals, Inc.
    • GEA Group Aktiengesellschaft
    • PBS Biotech Inc.
    • Applikon Biotechnology BV
    • Danaher Corporation
    • Merck KGaA
    • Shanghai Bailum Biotechnology Co., Ltd.
    • Solaris Biotechnology Srl.
    • ZETA GmbH

Browse Key Market Insights with Data Illustration:

In the News

  • June 2023 - Extending their cooperative agreement that started with upstream bioprocessing analytics, Waterways Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing. Bioprocess engineers will have access to more thorough analytical data for downstream batch and continuous manufacturing through software and hardware integrations between the SartoriusTM Resolute® BioSMBTM multi-column chromatography platform and the WatersTM PATROLTM UltraPerformance Liquid Chromatography (UPLCTM) Process Analysis System. This will improve yields while lowering waste and biomanufacturing costs.
  • August 2023 - Regeneron Pharmaceuticals, Inc. announced that it has reached a collaborative agreement with the Biomedical Advanced Research & Development Authority (BARDA) to facilitate the clinical development, clinical manufacturing, and regulatory licensure process of a novel COVID-19 monoclonal antibody therapy aimed at preventing SARS-CoV-2 infection. The deal is a component of the U.S. Department of Health and Human Services (HHS) "Project NextGen," which aims to develop a pipeline of novel COVID-19 vaccines and treatments.

Author Credits:  Radhika Pawar


  • Report ID: 5958
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of next-generation biomanufacturing is assessed at USD 25.67 billion.

The next-generation biomanufacturing market size was over USD 24.09 billion in 2024 and is projected to reach USD 67.11 billion by 2037, growing at around 8.2% CAGR during the forecast period i.e., between 2025-2037. Increased technological advancements, increased government initiatives for the advancement of biomanufacturing, and growing demand for drugs and therapies will drive the market growth.

North America industry is estimated to hold largest revenue share of 36% by 2037, due to presence of leading biopharmaceutical companies in the region.

The major players in the market include Sartorius AG, Regeneron Pharmaceuticals, Inc., GEA Group Aktiengesellschaft, PBS Biotech Inc., Applikon Biotechnology BV, Danaher Corporation, Merck KGaA, Shanghai Bailum Biotechnology Co., Ltd., Solaris Biotechnology Srl., ZETA GmbH
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample